Reproducibility of inhaled and subcutaneous insulin in Type 2 diabetic patients

被引：0

|

作者：

Perera, AD

Kapitza, C

Nosek, L

Heinemann, LW

Shapiro, DA

Fishman, RS

Heise, TC

机构：

[1] Aerogen Inc, Sunnyvale, CA USA

[2] Profil Inst Metab Res, Neuss, Germany

来源：

DIABETOLOGIA | 2001年 / 44卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

815

引用

收藏

页码：A212 / A212

页数：1

相关论文

共 50 条

[1] Dose-response relationships of inhaled and subcutaneous insulin in type 2 diabetic patients
Kim, D
Mudaliar, S
Plodkowski, R
Perera, A
Fishman, R
Shapiro, D
Henry, R
DIABETES, 2002, 51 : A47 - A47
[2] Dose-response relationships of inhaled and subcutaneous insulin in Type 2 diabetic patients.
Perera, AD
Fishman, RS
Shapiro, DA
Kim, DD
Mudaliar, S
Plodkowski, R
Henry, R
DIABETOLOGIA, 2002, 45 : A261 - A261
[3] A comparison of the pharmacodynamic effects of inhaled insulin versus subcutaneous insulin in Type 1 diabetic patients
Kipnes, M
Otulana, B
Clauson, P
Fischer, J
Farr, SJ
Hatorp, V
Schwartz, S
DIABETES, 1999, 48 : A95 - A95
[4] Inhaled insulin: clinical results in type 2 diabetic patients
Selam, JL
DIABETES & METABOLISM, 2001, 27 (05): : S28 - S32
[5] Pharmacokinetics and pharmacodynamics of subcutaneous applied insulin aspart administered with the FlexPen compared to inhaled insulin administered with the exubera device in type 1 and type 2 diabetic patients
Hohberg, Cloth
Forst, Thomas
Dehos, Barbara
Roth, Werner
Borchert, Marcus
Schoendorf, Thoams
Pfuetzner, Andreas
DIABETES, 2008, 57 : A561 - A561
[6] Low variability in metabolic action in type 2 diabetic patients with inhaled Technosphere™/Insulin
Pfützner, A
Rave, K
Heise, T
Steiner, S
Heinemann, L
DIABETOLOGIA, 2000, 43 : A202 - A202
[7] Psychological Insulin Resistance in Type 2 Diabetes Patients Regarding Oral Antidiabetes Treatment, Subcutaneous Insulin Injections, or Inhaled Insulin
Petrak, Frank
Herpertz, Stephan
Stridde, Elmar
Pfuetzner, Andreas
DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 (08) : 702 - 710
[8] Insulin Requirement Profiles and Characteristics of Type 2 Diabetic Patients With Continuous Subcutaneous Insulin Infusion Therapy
Zhang, Xiuzhen
Yan, Jinhua
Xu, Haixia
Xu, Wen
Yao, Bin
Zhu, Yanhua
Zhang, Guochao
Weng, Jianping
DIABETES, 2013, 62 : A248 - A249
[9] The effect of multiple subcutaneous insulin injections (MSII) on insulin secretion capacity in type 2 diabetic patients
Yoo, Soon-Jib
Lee, Seong Su
Kang, Moo Il
Lee, Kwang Woo
Son, Ho Young
Kang, Sung Koo
DIABETES, 2007, 56 : A547 - A547
[10] Impact of smoking on the metabolic action of subcutaneous regular insulin in type 2 diabetic patients
Bott, S
Shafagoj, YA
Sawicki, PT
Heise, T
HORMONE AND METABOLIC RESEARCH, 2005, 37 (07) : 445 - 449

← 1 2 3 4 5 →